SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk
SOXL 47.77-0.5%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: isopatch1/1/2022 4:30:04 PM
5 Recommendations

Recommended By
h_
roguedolphin
toccodolce
w0z
Winfastorlose

  Read Replies (1) of 207273
 
Six pgs, of FDA warnings!! See for yourselves threadsters: <Surprise: FDA Warns That Pfizer’s Experimental Covid Pills Cause Life-Threatening Reactions When Used with Many Common Medications

By Julian Conradson

Published December 31, 2021 at 11:01pm

Pfizer’s antiviral oral drug Paxlovid that was developed as an early treatment for Covid-19 can cause severe or life-threatening effects if it is taken in tandem with other common medications including some anticoagulants, anti-depressants, and cholesterol-lowering drugs that are used widely across the US, according to a warning from the Food and Drug Administration (FDA).

There are six pages of warnings with this drug.

pg 1



2


3



4


5


6


In addition to the potentially dangerous drug combinations, the agency does not recommend that individuals with kidney or liver disease take the new drug because it could also cause complications.

Pfizer’s Covid pill regiment – Paxlovid – consists of a mix of two drugs – one being nirmatrelvir, which is meant to stop the SARS-CoV-2 virus from replicating, and the second, ritonavir, is an agent that acts to prolong the duration of the first.

Like Pfizer’s Covid vaccine, the experimental drug has only been granted an Emergency Use Authorization (EUA) by the FDA.

The FDA granted Paxlovid its EUA just one month after Biden’s regime announced that it would be purchasing 10 million courses of the drug.

Paxlovid was the first antiviral oral medication of its kind that has been authorized for the treatment of Covid-19 even though other – more cost-effective – treatments have been proven to work and are widely available.

One such example of these cheap and safe treatments – Ivermectin – has not been approved in any capacity by the FDA to treat Covid-19, despite its strong results against the virus.

In fact, the US public health experts have refused to conduct any sort of large-scale clinical testing of Ivermectin’s effectiveness against Covid-19 throughout the pandemic in order to maintain plausible deniability that the treatment does not work against the China-virus.

Conveniently, this allows them to spend countless taxpayer dollars on the development and purchase of these more expensive treatments that haven’t even been proven to be safe, let alone effective.

But that hasn’t stopped other countries and entities from running clinical trials of their own to prove Ivermectin is a viable option to treat Covid. No surprise, the results show a sharp improvement in the prognosis of patients who have been diagnosed with Covid once Ivermectin is introduced.

Pfizer will begin delivery of its highly-profitable new drug immediately upon the start of 2022, continuing through the remainder of the year. The 10 million packs of Paxlovid will undoubtedly be just the starting point for the fraudulent Biden regime as they look to capitalize further on this manufactured pandemic.

Earlier in December, Pfizer announced that the pill is able to reduce the risk of hospitalization or death from the Covid-19 by as much as 89 percent when taken shortly after initial symptoms.>

thegatewaypundit.com

Be interesting to see how long the 6 pgs of warnings remain before being removed. Over & under guesses anyone?

Iso
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext